Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
The present disclosure provides for acid-resistant capsules comprising compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon. Compositions of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea, or C. difficile or the pseudo-membranous colitis associated with this infection.
1. An acid-resistant capsule comprising a saline suspension of a selected fraction of a fecal flora derived from a stool of a healthy human donor, wherein the fraction comprises uncultured bacteria from the phylum Firmicutes,
wherein the fraction is separate from rough particulate matter of the stool, and wherein the proportion of Firmicutes bacteria relative to non-Firmicutes bacteria in the fraction is greater than such proportion in the fecal flora.
2. The capsule of claim 1 , wherein the capsule is an enteric-coated capsule.
3. The capsule of claim 1 , wherein the saline suspension comprises a cryoprotectant.
4. The capsule of claim 3 , wherein the cryoprotectant comprises glycerol.
5. The capsule of claim 1 , wherein the fraction consists essentially of uncultured bacteria from the phylum Firmicutes.
6. The capsule of claim 1 , wherein an amount of non-floral material in the fraction is no greater than 1%.
7. The capsule of claim 1 , administered for the treatment of a Clostridium difficile infection.
8. An acid-resistant capsule comprising a saline suspension of a fraction of a fecal flora from a stool of a healthy human donor, wherein the fecal flora fraction comprises uncultured bacterial strains from the phylum Firmicutes,
wherein the fraction is separate from rough particulate matter of the stool, and wherein the proportion of Firmicutes bacteria relative to non-Firmicutes bacteria in the fecal flora fraction is greater than such proportion in the fecal flora.
9. The capsule of claim 8 , wherein the capsule is an enteric-coated capsule.
10. The capsule of claim 8 , wherein the saline suspension comprises a cryoprotectant.
11. The capsule of claim 10 , wherein the cryoprotectant comprises glycerol.
12. The capsule of claim 8 , wherein the fecal floral fraction consists essentially of uncultured bacterial strains from the phylum Firmicutes.
13. The capsule of claim 8 , wherein an amount of non-floral material in the fecal floral fraction is no greater than 1%.
14. The capsule of claim 8 , administered for the treatment of a Clostridium difficile infection.
15. The capsule of claim 8 , wherein the stool is pre-screened for infectious agents.